DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, has signed an agreement with Tunitas Therapeutics to provide process development activities for Tunitas’ lead Fc-fusion protein for the treatment of asthma and other allergic diseases.   DSM will manufacture drug product from its Groningen facility in The Netherlands and later at its Brisbane, Australia, facility. Tunitas recently established a subsidiary Tunitas Therapeutics Australia Pty Ltd. in M...